
More than 100 Americans have died after taking the drug hydroxychloroquine to treat or prevent coronavirus. This was found in …

The National Institutes of Health (NIH) have suspended clinical trials of hydroxychloroquine after the drug was found to have no …

The US is now sitting on a pile of 66 million anti-malaria pills, hydroxychloroquine and chloroquine, after they were removed …

The FDA has revoked its emergency approval of hydroxychloroquine and chloroquine due to health risks and a lack of effectiveness …

The Lancet’s editors have expressed their concerns over a paper published in their journal that said hydroxychloroquine and chloroquine was …

Counterfeit drugs that are falsely advertised to treat coronavirus have seen a surge in sales in parts of Africa. In …

Ousted Director of the Biomedical Advanced Research and Development Authority (BARDA), Dr Rick Bright, alleges the Trump administration ignored warnings …

The Association of American Physicians and Surgeons (AAPS) wrote a letter to Republican Arizona Governor Doug Ducey urging the wider …

The FDA has released a safety communication reiterating the need for doctors to closely monitor COVID-19 patients who are treated …

The malaria treatment hydroxychloroquine is facing further scrutiny as a coronavirus treatment after failed trials in France. The most recent …

The anti-malaria drug hydroxychloroquine does not speed up recovery from COVID-19, according to a new Chinese study. The study was …

Hydroxychloroquine dominates the latest coronavirus news this week. The anti-malaria drug, touted by President Trump as an effective COVID-19 treatment, …

A chloroquine study investigating its effects in treating the COVID-19 coronavirus in Brazil has been postponed for safety reasons. It …

President Trump continues to push the drug hydroxychloroquine as a potential coronavirus treatment despite a lack of evidence for its …

The European Medicines Agency has restricted the general use of the drug chloroquine for coronavirus, but allowing its testing in …